טוען...
Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
BACKGROUND: Receptor tyrosine kinases promote tumor progression in many cancers, although oncologic activation differs between diffuse-type gastric cancer (DGC) and intestinal-type gastric cancer (IGC). Fibroblast growth factor receptor (FGFR) is one RTK, and we previously reported the clinical sign...
שמור ב:
| הוצא לאור ב: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217622/ https://ncbi.nlm.nih.gov/pubmed/28056982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1081-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|